Skip to main content
. 2010 Aug 3;382(3):245–253. doi: 10.1007/s00210-010-0542-5

Fig. 5.

Fig. 5

Fibrinolytic activity of SMTP-7 and t-PA-treated embolic infarction models at 0, 1, and 3 h after drug administration. Drugs were administered at 1 h after ischemia. Fibrinolytic activity was identified as negative staining with CBB R-250 and expressed as a percentage of the positive control activity. Data represent the mean ± SEM of six experiments. *P < 0.05, **P < 0.01, statistically significant difference from control group